Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,278 | -52,649 | -25,047 | -67,675 | -46,789 |
| Depreciation Amortization | 545 | 43 | -30 | 612 | 539 |
| Accounts payable and accrued liabilities | -1,692 | 317 | 1,655 | 1,675 | 1,157 |
| Other Working Capital | -1,263 | -4,161 | -4,130 | 101 | -553 |
| Other Operating Activity | 20,588 | 11,673 | 3,564 | 11,738 | 8,545 |
| Operating Cash Flow | $-65,100 | $-44,777 | $-23,988 | $-53,549 | $-37,101 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,835 | -1,582 | -812 | -687 | -502 |
| Purchase Of Investment | 37,000 | 24,500 | N/A | -21,764 | -23,085 |
| Investing Cash Flow | $35,165 | $22,918 | $-812 | $-22,451 | $-23,587 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,305 | 7,234 | 6,855 | 187,631 | 94,582 |
| Financing Cash Flow | $7,305 | $7,234 | $6,855 | $187,631 | $94,582 |
| Beginning Cash Position | 193,238 | 193,238 | 193,238 | 81,607 | 81,607 |
| End Cash Position | 170,608 | 178,613 | 175,293 | 193,238 | 115,501 |
| Net Cash Flow | $-22,630 | $-14,625 | $-17,945 | $111,631 | $33,894 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,100 | -44,777 | -23,988 | -53,549 | -37,101 |
| Capital Expenditure | -1,835 | -1,582 | -812 | -687 | -502 |
| Free Cash Flow | -66,935 | -46,359 | -24,800 | -54,236 | -37,603 |